These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35573839)

  • 1. Targeting C-C Chemokine Receptor 5: Key to Opening the Neurorehabilitation Window After Ischemic Stroke.
    Feng YQ; Xu ZZ; Wang YT; Xiong Y; Xie W; He YY; Chen L; Liu GY; Li X; Liu J; Wu Q
    Front Cell Neurosci; 2022; 16():876342. PubMed ID: 35573839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the roles of CCR5 in learning and memory in normal and disordered states.
    Necula D; Riviere-Cazaux C; Shen Y; Zhou M
    Brain Behav Immun; 2021 Feb; 92():1-9. PubMed ID: 33276089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
    Louboutin JP; Strayer DS
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury.
    Joy MT; Ben Assayag E; Shabashov-Stone D; Liraz-Zaltsman S; Mazzitelli J; Arenas M; Abduljawad N; Kliper E; Korczyn AD; Thareja NS; Kesner EL; Zhou M; Huang S; Silva TK; Katz N; Bornstein NM; Silva AJ; Shohami E; Carmichael ST
    Cell; 2019 Feb; 176(5):1143-1157.e13. PubMed ID: 30794775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of C-C Chemokine Receptor 5 (CCR5) is Protective Against Cerebral Ischemia and Reperfusion Injury.
    Victoria ECG; de Brito Toscano EC; de Sousa Cardoso AC; da Silva DG; de Miranda AS; da Silva Barcelos L; Sugimoto MA; Sousa LP; de Assis Lima IV; de Oliveira ACP; Brant F; Machado FS; Teixeira MM; Teixeira AL; Rachid MA
    Curr Neurovasc Res; 2017; 14(2):125-131. PubMed ID: 28294064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of efficacious gait and upper limb functional interventions based on brain plasticity evidence and model-based measures for stroke patients.
    Daly JJ; Ruff RL
    ScientificWorldJournal; 2007 Dec; 7():2031-45. PubMed ID: 18167618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effect of C-C motif chemokine receptor 5 on ischemic stroke: More harm than benefit?
    Jing K; Chen F; Shi X; Guo J; Liu X
    Eur J Pharmacol; 2023 Aug; 953():175857. PubMed ID: 37321471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection.
    Basova L; Najera JA; Bortell N; Wang D; Moya R; Lindsey A; Semenova S; Ellis RJ; Marcondes MCG
    PLoS One; 2018; 13(6):e0199861. PubMed ID: 29944719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CC chemokine receptor 5-mediated signaling and HIV-1 Co-receptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion.
    Alkhatib G; Ahuja SS; Light D; Mummidi S; Berger EA; Ahuja SK
    J Biol Chem; 1997 Aug; 272(32):19771-6. PubMed ID: 9242636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine Receptors CC Chemokine Receptor 5 and C-X-C Motif Chemokine Receptor 4 Are New Therapeutic Targets for Brain Recovery after Traumatic Brain Injury.
    Liraz-Zaltsman S; Friedman-Levi Y; Shabashov-Stone D; Gincberg G; Atrakcy-Baranes D; Joy MT; Carmichael ST; Silva AJ; Shohami E
    J Neurotrauma; 2021 Jul; 38(14):2003-2017. PubMed ID: 33256497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of sleep in recovery following ischemic stroke: A review of human and animal data.
    Duss SB; Seiler A; Schmidt MH; Pace M; Adamantidis A; Müri RM; Bassetti CL
    Neurobiol Sleep Circadian Rhythms; 2017 Jan; 2():94-105. PubMed ID: 31236498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines and their receptors in the central nervous system.
    Bajetto A; Bonavia R; Barbero S; Florio T; Schettini G
    Front Neuroendocrinol; 2001 Jul; 22(3):147-84. PubMed ID: 11456467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.
    Scarlatti G; Tresoldi E; Björndal A; Fredriksson R; Colognesi C; Deng HK; Malnati MS; Plebani A; Siccardi AG; Littman DR; Fenyö EM; Lusso P
    Nat Med; 1997 Nov; 3(11):1259-65. PubMed ID: 9359702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.
    Dutta R; Roy S
    J Neuroinflammation; 2015 Jun; 12():120. PubMed ID: 26087960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque.
    Eitner F; Cui Y; Hudkins KL; Anderson DM; Schmidt A; Morton WR; Alpers CE
    Kidney Int; 1998 Dec; 54(6):1945-54. PubMed ID: 9853259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage inflammatory protein 1 and CCR5 as attractive therapeutic targets for HIV infection.
    Kasama T; Yajima N; Matsukura S; Adachi M
    Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):275-80. PubMed ID: 18221152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes.
    Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A
    Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.